Your browser doesn't support javascript.
loading
Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.
Haghdoost-Yazdi, Hashem; Piri, Hossein; Najafipour, Reza; Faraji, Ayda; Fraidouni, Negin; Dargahi, Tahereh; Alipour Heidari, Mahmud.
Afiliação
  • Haghdoost-Yazdi H; Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Neurosciences (Riyadh) ; 22(1): 44-50, 2017 01.
Article em En | MEDLINE | ID: mdl-28064330
ABSTRACT

OBJECTIVE:

To evaluate the effect of K+ channels inhibitors in treatment of parkinson`s disease (PD).

METHODS:

This prospective comparative study was conducted in the Qazvin University of Medical Sciences, Iran, from April 2015 to January 2016. Male rats (n=37) received intraperitoneal doses of TEA (2 and 5 mg/kg) or 4-AP (0.5 and 1 mg/kg) twice-daily, before a stereotactic injection of 6-hydroxydopamine (6-OHDA) for the following 7 days. The 6-OHDA was injected into right medial forebrain bundle (MFB) of the rat brains. Development and severity of PD were assessed using the apomorphine-induced rotational test, the elevated body swing test and rotarod tests. Concentration of malondialdehyde (MDA), a marker of oxidative stress, was measured in rat sera.

RESULTS:

Tetraethylammonium and 4-AP significantly reduced the number of apomorphine-induced rotations and improved motor learning in the rotarod test at both doses. Administration of 4-AP and TEA together was more effective than single administration of either agent. Malondialdehyde measurement showed that pretreatment with TEA could not prevent 6-OHDA-induced oxidative stress.

CONCLUSION:

Our results showed that pretreatment with TEA and 4-AP has a neuroprotective effect against 6-OHDA in dopaminergic neurons in the substantia nigra.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Secundária / 4-Aminopiridina / Oxidopamina / Tetraetilamônio / Bloqueadores dos Canais de Potássio / Antiparkinsonianos Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Revista: Neurosciences (Riyadh) Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Secundária / 4-Aminopiridina / Oxidopamina / Tetraetilamônio / Bloqueadores dos Canais de Potássio / Antiparkinsonianos Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Revista: Neurosciences (Riyadh) Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irã